Processa Pharmaceuticals, Inc. (PCSA) — 10-Q Filings

10-Q Filings (5)

• Processa's Losses Widen, Bets on Crypto for Future Funding — Nov 6, 2025 Risk: high
  Processa Pharmaceuticals, Inc. (PCSA) reported a net loss of $3,436,573 for the three months ended September 30, 2025, a slight increase from $3,384,703 in the
• Processa Pharmaceuticals Files Q1 2025 10-Q — May 8, 2025 Risk: medium
  Processa Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial position and operational results, includi
• Processa Pharmaceuticals Files Q3 2024 10-Q — Oct 30, 2024 Risk: medium
  Processa Pharmaceuticals, Inc. filed a 10-Q for the period ending September 30, 2024. The filing details financial information and operational updates for the t
• Processa Pharmaceuticals Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Processa Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its business o
• Processa Pharmaceuticals Files 10-Q for Q1 2024 — May 10, 2024 Risk: medium
  Processa Pharmaceuticals, Inc. (PCSA) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Processa Pharmaceuticals, Inc. filed a 10-Q for the period e

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX